New drug treatment for Parkinson's disease.
D018565:Food-Drug Interactions; D006801:Humans; D006973:Hypertension / Q000209:etiology; D007189:Indans / Q000009:adverse effects / Q000627:therapeutic use*; D008545:Melanoma / Q000139:chemically induced; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D018696:Neuroprotective Agents / Q000009:adverse effects / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*; D012878:Skin Neoplasms / Q000139:chemically induced
D007189:Indans; D008996:Monoamine Oxidase Inhibitors; D018696:Neuroprotective Agents; C031967:rasagiline